A 3.1%
Ru/UiO-66 material was prepared by adsorption of RuCl
3
from
ethyl acetate on to MOF UiO-66, followed by reduction
with NaBH
4
. The presence of acid–base and ox-red
sites allows this 3.1% Ru/UiO-66 material acting as a bifunctional
catalyst for the reduction of nitroarenes and tandem reaction of alcohol
oxidation/Knoevenagel condensation. The high efficiency of 3.1% Ru/UiO-66
was demonstrated in the reduction of nitroarenes to amines. This system
can be applied as a catalyst for at least six successive cycles without
loss of activity. The 3.1% Ru/UiO-66 catalyst also was active in the
tandem aerobic oxidation of alcohols/Knoevenagel condensation with
malononitrile. However, the activity of this catalyst strongly decreased
in the second cycle. A combination of physicochemical and catalytic
experimental data indicated that Ru nanoparticles are the active sites
both for the catalytic reduction of nitro compounds and the aerobic
oxidation of alcohols. The activity for the Knoevenagel condensation
reaction was from the existence of the “Zr
n
+
–O
2–
Lewis acid–base”
pair in the framework of UiO-66.
Disclosed herein is a direct C−H trifluoromethylation of quinoxalin‐2(1H)‐ones with sodium trifluoromethanesulfinate. This protocol affords a series of 3‐trifluoromethylquinoxalin‐2(1H)‐one derivatives in moderate to excellent yields under transition‐metal‐free conditions. The present methodology features utilization of the inexpensive trifluoromethyl source without transition‐metal‐catalysts, mild reaction conditions and high functional group tolerance, which promises a convenient and efficient access to pharmaceutically interesting quinoxalinones.magnified image
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.